BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36654075)

  • 1. An explorative study for leveraging transcriptomic data of embryonic stem cells in mining cancer stemness genes, regulators, and networks.
    Yang J; Xu H; Li C; Li Z; Hu Z
    Math Biosci Eng; 2022 Sep; 19(12):13949-13966. PubMed ID: 36654075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer.
    Serrano-Oviedo L; Nuncia-Cantarero M; Morcillo-Garcia S; Nieto-Jimenez C; Burgos M; Corrales-Sanchez V; Perez-Peña J; Győrffy B; Ocaña A; Galán-Moya EM
    Cell Oncol (Dordr); 2020 Jun; 43(3):431-444. PubMed ID: 32166583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management.
    Glinsky GV
    J Clin Oncol; 2008 Jun; 26(17):2846-53. PubMed ID: 18539963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for embryonic stem-like signature and epithelial-mesenchymal transition features in the spheroid cells derived from lung adenocarcinoma.
    Roudi R; Madjd Z; Ebrahimi M; Najafi A; Korourian A; Shariftabrizi A; Samadikuchaksaraei A
    Tumour Biol; 2016 Sep; 37(9):11843-11859. PubMed ID: 27048287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
    Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
    J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired resistance to metformin in breast cancer cells triggers transcriptome reprogramming toward a degradome-related metastatic stem-like profile.
    Oliveras-Ferraros C; Vazquez-Martin A; Cuyàs E; Corominas-Faja B; Rodríguez-Gallego E; Fernández-Arroyo S; Martin-Castillo B; Joven J; Menendez JA
    Cell Cycle; 2014; 13(7):1132-44. PubMed ID: 24553122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptome analysis reveals high tumor heterogeneity with respect to re-activation of stemness and proliferation programs.
    Baranovsky A; Ivanov T; Granovskaya M; Papatsenko D; Pervouchine DD
    PLoS One; 2022; 17(5):e0268626. PubMed ID: 35587924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of SOX2 expression delineates an end-point for paclitaxel-effectiveness in breast cancer stem cells.
    Mukherjee P; Gupta A; Chattopadhyay D; Chatterji U
    Sci Rep; 2017 Aug; 7(1):9170. PubMed ID: 28835684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of cancer stem cell characteristics in liver hepatocellular carcinoma by WGCNA analysis of transcriptome stemness index.
    Bai KH; He SY; Shu LL; Wang WD; Lin SY; Zhang QY; Li L; Cheng L; Dai YJ
    Cancer Med; 2020 Jun; 9(12):4290-4298. PubMed ID: 32311840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
    Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G
    Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer.
    Zheng H; Liu H; Li H; Dou W; Wang J; Zhang J; Liu T; Wu Y; Liu Y; Wang X
    Stem Cell Res Ther; 2022 Jun; 13(1):244. PubMed ID: 35681225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An integrated analysis to predict micro-RNAs targeting both stemness and metastasis in breast cancer stem cells.
    Rahimi M; Sharifi-Zarchi A; Firouzi J; Azimi M; Zarghami N; Alizadeh E; Ebrahimi M
    J Cell Mol Med; 2019 Apr; 23(4):2442-2456. PubMed ID: 30710426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of hTERT and stemness genes in BORIS/CTCFL positive cells isolated from embryonic cancer cells.
    Alberti L; Renaud S; Losi L; Leyvraz S; Benhattar J
    PLoS One; 2014; 9(10):e109921. PubMed ID: 25279549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer.
    Asaduzzaman M; Constantinou S; Min H; Gallon J; Lin ML; Singh P; Raguz S; Ali S; Shousha S; Coombes RC; Lam EW; Hu Y; Yagüe E
    Breast Cancer Res Treat; 2017 Jun; 163(3):461-474. PubMed ID: 28341962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
    Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
    PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying cancer subtypes based on embryonic and hematopoietic stem cell signatures in pan-cancer.
    Lei J; Luo J; Liu Q; Wang X
    Cell Oncol (Dordr); 2024 Apr; 47(2):587-605. PubMed ID: 37821797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptome-based identification of lovastatin as a breast cancer stem cell-targeting drug.
    Vásquez-Bochm LX; Velázquez-Paniagua M; Castro-Vázquez SS; Guerrero-Rodríguez SL; Mondragon-Peralta A; De La Fuente-Granada M; Pérez-Tapia SM; González-Arenas A; Velasco-Velázquez MA
    Pharmacol Rep; 2019 Jun; 71(3):535-544. PubMed ID: 31026757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian cancer stem cell-specific gene expression profiling and targeted drug prescreening.
    Huang Y; Ju B; Tian J; Liu F; Yu H; Xiao H; Liu X; Liu W; Yao Z; Hao Q
    Oncol Rep; 2014 Mar; 31(3):1235-48. PubMed ID: 24424387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Glioma Cancer Stem Cell Characteristics Based on Weighted Gene Prognosis Module Co-Expression Network Analysis of Transcriptome Data Stemness Indices.
    Xia P; Li Q; Wu G; Huang Y
    J Mol Neurosci; 2020 Oct; 70(10):1512-1520. PubMed ID: 32451841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway.
    Corominas-Faja B; Cufí S; Oliveras-Ferraros C; Cuyàs E; López-Bonet E; Lupu R; Alarcón T; Vellon L; Iglesias JM; Leis O; Martín ÁG; Vazquez-Martin A; Menendez JA
    Cell Cycle; 2013 Sep; 12(18):3109-24. PubMed ID: 23974095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.